Skip to main content
SpringerLink
Log in

Neuer Pfeil im Therapieköcher gegen Asthma von Kindern

  • Literatur kompakt
  • Published:
Allergo Journal Aims and scope Submit manuscript

Die Palette von Medikamenten für die Kontrolle von Asthma im Kindesalter hat Zuwachs bekommen: Der langwirksame Muskarinantagonist Tiotropium ergänzt die Optionen für die Add-on-Therapie.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Hamelmann E. Long-acting muscarinic antagonists for the treatment of asthma in children — a new kid in town. Allergo J Int 2018;27:220–7

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Robert Bublak

  2. Klinik für Dermatologie und Allergologie, Universitätsklinikum Gießen u. Marburg, Standort Gießen, Deutschland

    Thilo Jakob (Direktor)

Authors
  1. Robert Bublak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thilo Jakob
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bublak, R., Jakob, T. Neuer Pfeil im Therapieköcher gegen Asthma von Kindern. Allergo J 27, 14–15 (2018). https://doi.org/10.1007/s15007-018-1716-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-018-1716-6

Search

Navigation